Success Metrics

Clinical Success Rate

72.7%

Based on 8 completed trials

Completion Rate

73%(8/11)

Active Trials

1(8%)

Results Posted

63%(5 trials)

Terminated

3(23%)

Phase Distribution

Ph phase_4

31%

Ph phase_1

23%

Ph phase_2

23%

Ph not_applicable

23%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution13 total trials

Phase 1Safety & dosage

3(23.1%)

Phase 2Efficacy & side effects

3(23.1%)

Phase 4Post-market surveillance

4(30.8%)

N/ANon-phased studies

3(23.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

8 of 12 finished

Non-Completion Rate

33.3%

4 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(8)

Terminated(4)

Detailed Status

Completed8

Terminated3

Recruiting1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

72.7%

Most Advanced

Phase 4

Trials by Phase

Phase 13 (23.1%)

Phase 23 (23.1%)

Phase 44 (30.8%)

N/A3 (23.1%)

Trials by Status

recruiting18%

completed862%

terminated323%

withdrawn18%

Recent Activity

1 active trials

Showing 5 of 13

completedphase_2

Clinical Trials (13)

Showing 13 of 13 trials

NCT05962957Phase 2

Role of Pentoxifylline and Celecoxib in Parkinsonism

Completed

NCT05285683Phase 2

The Role of Brain Dopamine in Chronic Pain

Recruiting

NCT03451500Phase 2

Carbidopa-Levodopa in Dry AMD With Geographic Atrophy

Terminated

NCT04493320Phase 4

1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)

Terminated

NCT04650217Phase 4

Levodopa and Exercise for Older Adults With Depression and Psychomotor Slowing

Terminated

NCT03929068Phase 1

Sinemet for Spasticity and Function in Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis

Completed

NCT01951105Phase 4

Effect of L-dopa In Subacute Back Pain Population

Completed

NCT03761004Phase 1

WD-1603 PK Study in Healthy Volunteers

Completed

NCT01528592Not Applicable

PharmacoMRI of Parkinson Disease

Completed

NCT00715520Not Applicable

Neurobiological Principles Applied to the Rehabilitation of Stroke Patients

Completed

NCT00223691Phase 1

Treatment of Orthostatic Hypotension in Autonomic Failure

Completed

NCT00601978Phase 4

Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off

Withdrawn

NCT00129181Not Applicable

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease

Completed

All 13 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 13